Table 1 Baseline characteristics of the participants.
Parameter | control group | AURI group | KD-NCAL group | KD-CAL group | F/χ2 | P |
---|---|---|---|---|---|---|
(n = 100) | (n = 30) | (n = 130) | (n = 50) | |||
Age (months) | 31 (20~40) | 30 (17~45) | 33 (20~43) | 28 (18~38) | 4.101 | 0.250 |
Gender male | 65 | 16 | 80 | 30 | 1.410 | 0.703 |
       female | 35 | 14 | 50 | 20 |  |  |
DC(ms) | 6.06 (5.23~6.69) | 5.43 (4.76~6.23)a | 5.47 (4.77~5.95)a | 3.70 (2.68~5.37)a, b, c | 60.027 | <0.001 |
PNN50(%) | 16 (8~28) | 10 (5~19)a | 9 (2~16)a | 3 (0~10)a, b, c | 56.470 | <0.001 |
rMSSD(ms) | 45 (33~58) | 42 (30~55) | 37 (29~45)a | 32 (26~42)a, b | 21.507 | <0.001 |
HF(ms2) | 393.7(226.1~572.6) | 146.4 (82.5~229.9)a | 118.5 (54.1~202.0)a | 70.3 (40.7~190.7)a, b | 123.624 | <0.001 |
NT-proBNP (pg/ml) | — | 105 (74~120) | 398 (118~819)b | 867 (709~987)b, c | 65.583 | <0.001 |
CRP (mg/dl) | — | 1.5 (0.9~1.9) | 3.9 (2.8~5.1)b | 6.3 (3.9~12.7)b, c | 88.325 | <0.001 |